Skip to main content

Kurma Partners — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

85
Companies
$2.6B
Total invested
$30.5M
Avg. check
24
Industries
Health Care 16Biotechnology 14Pharmaceutical 6Medical 6Therapeutics 5Fitness 3+18 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 85
PanTera
September 2024

PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.

Health Care · Mol$110.3M Series A
Asceneuron
July 2024

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Biotechnology · Lausanne$100.0M Series C
Spotlight Medical
July 2024

Spotlight Medical develops AI tests to revolutionize cancer treatment, providing everyone with the best possible chance to beat cancer.

Artificial Intelligence (AI) · Paris$6.8M Seed
SciRhom
July 2024

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

Biotechnology · Martinsried$68.1M Series A
Vico Therapeutics
June 2024

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Health Care · Leiden$12.3M Series B
FeetMe
June 2024

FeetMe is a digital health company that provides a technology platform for in-clinic and real-world gait and activity assessments.

Fitness · ParisSeries B
Memo Therapeutics
May 2024

Memo Therapeutics is a biotechnology research company that engages in antibody discovery and immune repertoire analysis.

Biotechnology · Schlieren$22.0M Series C
Safe Orthopaedics
March 2024

Safe Orthopaedics is a France-based company principally engaged in the medical devices industry.

Health Care · Californië$929K Post-IPO Debt
Stilla Technologies
February 2024

Stilla Technologies is a Paris-based european biotechnology company.

Biotechnology · Villejuif$26.5M Series C
Vivet Therapeutics
February 2024

Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.

Biopharma · Paris$5.3M Grant
BioSerenity
November 2023

BioSerenity provides remote monitoring and diagnostic software for healthcare sectors.

Health Care · Paris$25.7M Venture - Series Unknown
Shorla Pharma
October 2023

Shorla Pharma is an Irish specialty pharmaceutical company.

Biotechnology · Clonmel$35.0M Series B
Corteria Pharmaceuticals
September 2023

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Biotechnology · Paris$69.5M Series A
Axithra
September 2023

Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.

Biotechnology · Genk$10.7M Seed
Xeltis
August 2023

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Health Care · Eindhoven$13.6M Series D
Kiro
March 2023

Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.

Artificial Intelligence (AI) · Paris$15.0M Series A
Ganymed Robotics
January 2023

Ganymed Robotics develops smart robots for orthopedic surgery.

Robotics · Paris$15.9M Series B
Ermium Therapeutics
June 2022

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

Biotechnology · Paris$6.3M Series A
NaoX Technologies
January 2022

NaoX Technologies develops wireless headphones that listen to brain vibrations.

Fitness · Palaiseau$4.8M Seed
PathoQuest
November 2021

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

Biotechnology · Paris$17.4M Series B
Charles.co
March 2026

Charles helps men regain control over their daily health concerns by starting with their personal health.

Fitness · Paris$297K Secondary Market
Step Pharma
February 2026

Step Pharma is a biotechnology company.

Biotechnology · Paris$2.9M Grant
Alveus Therapeutics
January 2026

Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.

Biotechnology · Philadelphia$197.0M Series A
Laigo Bio
December 2025

Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.

Biotechnology · Utrecht$13.4M Seed

Where Kurma Partners invests

Health Care16
Biotechnology14
Pharmaceutical6
Medical6
Therapeutics5
Fitness3

About Kurma Partners's portfolio

How many companies has Kurma Partners invested in?▸

Kurma Partners has invested in 85 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Kurma Partners invest in?▸

Kurma Partners's top investment sectors include Health Care, Biotechnology, Pharmaceutical, Medical, Therapeutics. The firm invests across 24 different industry categories.

What is Kurma Partners's largest investment?▸

Among tracked funding rounds, Alveus Therapeutics received $197.0M in a Series A round. Kurma Partners's total known invested capital is $2.6B.

What is the average investment size for Kurma Partners?▸

Kurma Partners's average investment size is $30.5M across its portfolio of 85 companies.

What are Kurma Partners's most recent investments?▸

Recent Kurma Partners portfolio additions include PanTera, Asceneuron, Spotlight Medical, SciRhom, Vico Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 85 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →